11 min read
Monthly FDA Guidance and Regulatory News Review - June 2026
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
SFL, a Veristat company, is attending the 28th Annual Swiss Symposium in Pharmaceutical Medicine 2023
28th Annual Swiss Symposium in Pharmaceutical Medicine 2023, 29th November, at Musikschule, Florhofgasse 6, Zurich, Switzerland.
This year’s Annual Symposium in Pharmaceutical Medicine is focusing on Patient Engagement from the perspectives of clinical trials, drug development, and the safe use of medicinal products. It is essential that patients are properly informed using lay language summaries to enable them to make educated decisions. Drug shortages, particularly in crisis regions, are a tremendous problem, especially for patients with chronic diseases. The Symposium will bring to light these important issues and more.
Anja Buhrer, Vice President Regulatory Affairs and Deputy Head at SFL, and Delphine Guérin, Director Business Development and Project Management at SFL, a Veristat Company, are attending the Symposium. We look forward to connecting with you at the SFL booth and to discuss how we may support your projects.
Website: SwAPP Conference 2023

Meet with us at the 28th Annual Swiss Symposium in Pharmaceutical Medicine 2023 by filling out the form below.
11 min read
Jul 7, 2026 Veristat Blog
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
2 min read
Jul 2, 2026 Veristat Blog
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...